Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on September 13, 2007

Arteriosclerosis, Thrombosis, and Vascular Biology. 2007
Published online before print September 13, 2007, doi: 10.1161/ATVBAHA.107.149872
A more recent version of this article appeared on October 1, 2007
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
27/10/2266    most recent
ATVBAHA.107.149872v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ohmori, T.
Right arrow Articles by Sakata, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohmori, T.
Right arrow Articles by Sakata, Y.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH

Submitted on March 26, 2007
Accepted on July 19, 2007

Silencing of a Targeted Protein in In Vivo Platelets Using a Lentiviral Vector Delivering Short Hairpin RNA Sequence

Tsukasa Ohmori *; Yuji Kashiwakura ; Akira Ishiwata ; Seiji Madoiwa ; Jun Mimuro ; and Yoichi Sakata

From the Research Division of Cell and Molecular Medicine, Center for Molecular Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.

* To whom correspondence should be addressed. E-mail: tohmori{at}jichi.ac.jp.

Objective—Because platelets are anucleate cells having a limited life span, direct gene manipulation cannot in principle be used to investigate the involvement of a specific signal transduction pathway in platelet activation. In this study, we examined whether the expression of a short hairpin RNA (shRNA) sequence in hematopoietic stem cells is maintained during megakaryocyte differentiation, thus resulting in inhibition of targeted protein in platelets.

Methods and Results—To identify platelets derived from transduced stem cells, we generated a lentiviral vector that simultaneously expresses the shRNA sequence driven by the U6 promoter and GFP under the control of the glycoprotein (GP) Ib{alpha} promoter. Transplantation of mouse bone marrow cells transduced with the vector facilitated specifically mark platelets derived from the transduced cells. Transplantation of cells transduced with shRNA sequence targeting integrin {alpha}IIb caused a significant reduction of integrin {alpha}IIb{beta}3 ({alpha}IIb{beta}3) expression in GFP-positive platelets. It also inhibited {alpha}IIb{beta}3 activation assessed by the binding of JON/A, an antibody that recognizes activated {alpha}IIb{beta}3. Talin-1 silencing by the same method resulted in normal {alpha}IIb{beta}3 expression but deficient inside-out {alpha}IIb{beta}3 signaling.

Conclusions—shRNA expression driven by the U6 promoter is preserved during megakaryopoiesis. This method facilitates functional analysis of targeted protein in platelet activation.


Key words: shRNA • RNA interference • platelets • talin • integrin




This article has been cited by other articles:


Home page
BloodHome page
L. Gilles, D. Bluteau, S. Boukour, Y. Chang, Y. Zhang, T. Robert, P. Dessen, N. Debili, O. A. Bernard, W. Vainchenker, et al.
MAL/SRF complex is involved in platelet formation and megakaryocyte migration by regulating MYL9 (MLC2) and MMP9
Blood, November 5, 2009; 114(19): 4221 - 4232.
[Abstract] [Full Text] [PDF]